Literature DB >> 8701615

[Occupational status and prevalence of cardiovascular risk indicators in employed men in German-speaking Switzerland].

I Foppa1, R Calmonte, H Noack, T Abelin.   

Abstract

Based on a sample of 623 employed men from the Berne Workplace Health Project ("Härz-As-Project") we studied the relationship between the occupational status and prevalence of cardiovascular risk indicators. Besides "biological" risk indicators, like high total cholesterol, low HDL-cholesterol, hypertension, and overweight, we also studied two behavioral risk indicators (current smoking, physical inactivity in leisure time) and a summary risk score. Odds ratios for several risk indicators controlled for age, were markedly different among different occupational status groups. High cholesterol/HDL-cholesterol ratios were more common in lower occupational status groups, while the likelihood for hypertension and high total cholesterol was highest among qualified workers. There was a strong association between occupational status and the behavioral risk indicators smoking and physical inactivity in leasure time. Similarly, 1 or more risk indicators, and more than 2 risk indicators, respectively, were also found to be strongly related to occupational status. Our results confirm former findings of unequal distribution of cardiovascular disease risk indicators among groups of different occupational status. Future studies will have to focus upon the underlying causes for these inequities.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8701615     DOI: 10.1007/bf01358842

Source DB:  PubMed          Journal:  Soz Praventivmed        ISSN: 0303-8408


  21 in total

1.  Social inequities in cardiovascular disease risk factors in East and West Germany.

Authors:  U Helmert; A Mielck; E Classen
Journal:  Soc Sci Med       Date:  1992-11       Impact factor: 4.634

2.  Social mobility and the interpretation of social class mortality differentials.

Authors:  J Stern
Journal:  J Soc Policy       Date:  1983-01

3.  Measuring health lifestyles in a comparative analysis: theoretical issues and empirical findings.

Authors:  T Abel
Journal:  Soc Sci Med       Date:  1991       Impact factor: 4.634

4.  Social class and risk factors for coronary heart disease in the Federal Republic of Germany. Results of the baseline survey of the German Cardiovascular Prevention Study (GCP).

Authors:  U Helmert; B Herman; K H Joeckel; E Greiser; J Madans
Journal:  J Epidemiol Community Health       Date:  1989-03       Impact factor: 3.710

5.  Social class gradients in years of potential life lost in Switzerland.

Authors:  V Beer; B Bisig; F Gutzwiller
Journal:  Soc Sci Med       Date:  1993-10       Impact factor: 4.634

6.  Coronary risk factors and socioeconomic status in Eastern Finland.

Authors:  J Tuomilehto; P Puska; J Virtamo; L Neittaanmäki; K Koskela
Journal:  Prev Med       Date:  1978-12       Impact factor: 4.018

7.  [Total cholesterol, HDL-cholesterol and blood pressure in relation to life style: results of the first population screening of the Swiss MONIKA Project].

Authors:  B Marti; S Dai; M Rickenbach; V Wietlisbach; C Bucher; F Barazzoni; F Gutzwiller
Journal:  Schweiz Med Wochenschr       Date:  1990-12-29

8.  [Mortality differences according to socioeconomic group in Switzerland 1980: 15 to 74-year-old males].

Authors:  C E Minder; V Beer; R Rehmann
Journal:  Soz Praventivmed       Date:  1986

9.  Social status and coronary heart disease: results from the Scottish Heart Health Study.

Authors:  M Woodward; M C Shewry; W C Smith; H Tunstall-Pedoe
Journal:  Prev Med       Date:  1992-01       Impact factor: 4.018

10.  Epidemiological approach to the explanation of social differentiation in mortality: the Whitehall studies.

Authors:  M Marmot
Journal:  Soz Praventivmed       Date:  1993
View more
  1 in total

1.  [Arguments and basic principles for continuous monitoring of social differences in the health of Swiss children].

Authors:  B Schär; J C Vuille; R Westkämper
Journal:  Soz Praventivmed       Date:  1999
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.